Instil Bio(TIL)
DALLAS, TXBiotechnology
Focus: Instil Bio is a Dallas-based cell therapy company focused on developing TIL (tumor-infiltrating lymphocyte) and other cell-based immunotherapies for oncology. Public since 2008 with a lean, early-stage pipeline.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Instil Bio
AI assessmentNot HiringNo open roles listed right now. Follow Instil Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AXN-2510
Solid Tumor, AdultClinical Trials (1)
NCT07159828A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors
Phase 1Help build intelligence for Instil Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.